Does Your Biologics CDMO Truly Have A Culture Of Quality?

By Joe Payne, Scorpius BioManufacturing and Tonia Becker, Nice Insight

Claiming a "culture of quality" is becoming ubiquitous in the biopharmaceutical industry. But understanding what it truly means and learning how to discern genuine commitment from mere buzzwords when choosing a biologics CDMO is paramount when forging a successful manufacturing partnership.

In this interview, Joe Payne, Vice President of Quality and Regulatory Affairs at Scorpius BioManufacturing, shares a roadmap for discerning authenticity in the industry. Joe boasts an illustrious career in quality management and regulatory affairs, traversing industry giants like Teva Pharmaceuticals, Alcami, and Tergus before landing at Scorpius. Joe delves into his experience and paints a vivid picture of what an effective quality and compliance system truly entails.

Learn how to navigate the sea of "quality claims" and find a CDMO partner that is earnestly committed to a culture of quality, placing patient safety and product excellence at the core of their operations.